The increasing demand for specific immunological research and therapeutic creation has spurred significant progress in recombinant cytokine manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently manufactured using diverse expression platforms, including microbial hosts, mammalian cell cultures, and vir